BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 38102305)

  • 21. Complications and 5-year survival after radical resections which include urological organs for locally advanced and recurrent pelvic malignancies: analysis of 646 consecutive cases.
    Peacock O; Waters PS; Kong JC; Warrier SK; Wakeman C; Eglinton T; Murphy DG; Heriot AG; Frizelle FA; McCormick JJ
    Tech Coloproctol; 2020 Feb; 24(2):181-190. PubMed ID: 31907722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Robotic surgery for locally advanced T4 rectal cancer: feasibility and oncological quality.
    Gomez Ruiz M; Ballestero Diego R; Tejedor P; Cagigas Fernandez C; Cristobal Poch L; Suarez Pazos N; Castillo Diego J
    Updates Surg; 2023 Apr; 75(3):589-597. PubMed ID: 36763301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in Surgical Outcomes and Quality-of-Life Outcomes in Pelvic Exenteration Between Locally Advanced Versus Locally Recurrent Rectal Cancers.
    Huang Y; Steffens D; Koh CE; Young JM; Solomon MJ
    Dis Colon Rectum; 2022 Dec; 65(12):1475-1482. PubMed ID: 35913831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pelvic exenteration and composite sacral resection in the surgical treatment of locally recurrent rectal cancer.
    Gawad W; Khafagy M; Gamil M; Fakhr I; Negm M; Mokhtar N; Lotayef M; Mansour O
    J Egypt Natl Canc Inst; 2014 Sep; 26(3):167-73. PubMed ID: 25150132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pelvic exenteration for chronic fistulating pelvic sepsis after multimodal treatment of pelvic malignancy.
    Brown KGM; Risbey C; Solomon MJ; Austin KKS; Lee PJ; Byrne CM
    Eur J Surg Oncol; 2023 Dec; 49(12):107124. PubMed ID: 37879161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Robotic beyond total mesorectal excision for locally advanced rectal cancers: Perioperative and oncological outcomes from a multicentre case series.
    Khan JS; Piozzi GN; Rouanet P; Saklani A; Ozben V; Neary P; Coyne P; Kim SH; Garcia-Aguilar J
    Eur J Surg Oncol; 2024 Jun; 50(6):108308. PubMed ID: 38583214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Results of laparoscopic pelvic exenterations].
    Sanzharov AE; Gallyamov EA; Sergeev VP; Biktimirov RG; Aminova LN; Kochkin AD; Meshchankin IV; Agapov MA; Gololobov GY
    Khirurgiia (Mosk); 2022; (7):45-57. PubMed ID: 35775844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systematic review of outcomes following pelvic exenteration for the treatment of primary and recurrent locally advanced rectal cancer.
    Platt E; Dovell G; Smolarek S
    Tech Coloproctol; 2018 Nov; 22(11):835-845. PubMed ID: 30506497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Feasibility and safety of minimally invasive multivisceral resection for T4b rectal cancer: A 9-year review.
    Chan KS; Liu B; Tan MNA; How KY; Wong KY
    World J Gastrointest Surg; 2024 Mar; 16(3):777-789. PubMed ID: 38577068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Updated systematic review of the approach to pelvic exenteration for locally advanced primary rectal cancer.
    Fahy MR; Hayes C; Kelly ME; Winter DC
    Eur J Surg Oncol; 2022 Nov; 48(11):2284-2291. PubMed ID: 35031157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparing minimally invasive surgical and open approaches to pelvic exenteration for locally advanced or recurrent pelvic malignancies - Systematic review and meta-analysis.
    Ryan OK; Doogan KL; Ryan ÉJ; Donnelly M; Reynolds IS; Creavin B; Davey MG; Kelly ME; Kennelly R; Hanly A; Martin ST; Winter DC
    Eur J Surg Oncol; 2023 Aug; 49(8):1362-1373. PubMed ID: 37087374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extended lateral pelvic sidewall excision (ELSiE): an approach to optimize complete resection rates in locally advanced or recurrent anorectal cancer involving the pelvic sidewall.
    Shaikh I; Aston W; Hellawell G; Ross D; Littler S; Burling D; Marshall M; Northover JM; Antoniou A; Jenkins JT
    Tech Coloproctol; 2014 Dec; 18(12):1161-8. PubMed ID: 25380742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Excellent Outcomes After Extended Radical Pelvic Resection for Locally Advanced and Recurrent IBD-Associated Anorectal Cancer.
    Chang KH; Brown KGM; Chen Lau Y; Solomon MJ
    Dis Colon Rectum; 2021 Feb; 64(2):209-216. PubMed ID: 33315717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgical outcomes in pelvic exenteration for advanced and recurrent malignancy: a high volume single institution experience.
    De Crignis L; Dupré A; Meeus P; Peyrat P; Rivoire M
    Langenbecks Arch Surg; 2023 Jun; 408(1):221. PubMed ID: 37261533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes of Pelvic Exenteration with en Bloc Partial or Complete Pubic Bone Excision for Locally Advanced Primary or Recurrent Pelvic Cancer.
    Austin KK; Herd AJ; Solomon MJ; Ly K; Lee PJ
    Dis Colon Rectum; 2016 Sep; 59(9):831-5. PubMed ID: 27505111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bladder preserving robotic pelvic exenteration for locally advanced rectal cancer-technique and short-term outcomes.
    Jaganmurugan R; Kazi M; Sukumar V; Gori J; Prakash G; Pal M; Bakshi G; de Souza A; Saklani A
    J Surg Oncol; 2022 Mar; 125(3):493-497. PubMed ID: 34661920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pelvic exenteration and sacral resection for locally advanced primary and recurrent rectal cancer.
    Yamada K; Ishizawa T; Niwa K; Chuman Y; Aikou T
    Dis Colon Rectum; 2002 Aug; 45(8):1078-84. PubMed ID: 12195193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Urinary complications of pelvic exenterations for rectal cancer with urinary invasion].
    Gas J; Beauval JB; Chalret du Rieu M; Bou Nasr E; Philis A; Kirzin S; Thoulouzan M; Soulié M; Ghouti L
    Prog Urol; 2015 May; 25(6):348-54. PubMed ID: 25804429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utilization and perioperative outcome of minimally invasive pelvic exenteration in gynecologic malignancies: A national study in the United States.
    Matsuo K; Matsuzaki S; Mandelbaum RS; Kanao H; Chang EJ; Klar M; Roman LD; Wright JD
    Gynecol Oncol; 2021 Apr; 161(1):39-45. PubMed ID: 33402282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 10-year experience of total pelvic exenteration for primary advanced and locally recurrent rectal cancer based on a prospective database.
    Nielsen MB; Rasmussen PC; Lindegaard JC; Laurberg S
    Colorectal Dis; 2012 Sep; 14(9):1076-83. PubMed ID: 22107085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.